Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

CONCORD BIOTECH LTD.

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private

BSE1988.5590.05 (+4.74 %)

PREV CLOSE ( ) 1898.50

OPEN PRICE ( ) 1898.55

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 11304

TODAY'S LOW / HIGH ( )1898.50 2020.00

52 WK LOW / HIGH ( )1206 2658

NSE1991.2090.3 (+4.75 %)

PREV CLOSE( ) 1900.90

OPEN PRICE ( ) 1905.95

BID PRICE (QTY) 1991.20 (33)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 396104

TODAY'S LOW / HIGH( ) 1905.00 2019.00

52 WK LOW / HIGH ( )1205.45 2664

Quarters

Select year

( in Million)

Particulars

Sep 2024

Jun 2024

Mar 2024

Dec 2023

Audited / UnAudited

UnAudited

Net Sales

3101.81

2158.02

3189.69

2407.96

Total Expenditure

1735.03

1345.23

1846.81

1348.67

PBIDT (Excl OI)

1366.78

812.79

1342.88

1059.29

Other Income

100.26

103.08

108.12

81.87

Operating Profit

1467.04

915.86

1451

1141.17

Interest

0.96

2.41

4.63

4.95

Exceptional Items

PBDT

1466.08

913.45

1446.37

1136.22

Depreciation

133.14

131.78

137.18

135.37

Profit Before Tax

1332.94

781.67

1309.19

1000.85

Tax

345.94

199.28

337.04

255.31

Provisions and contingencies

Profit After Tax

987

582.39

972.15

745.54

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

987

582.39

972.15

745.54

Minority Interest

Shares of Associates

-29.59

13.54

-21.98

30.2

Other related items

Misc. Expenses Written off

Consolidated Net Profit

957.41

595.93

950.16

775.73

Equity Capital

104.62

Face Value (IN RS)

Reserves

Calculated EPS

9.15

5.69

9.08

7.41

Calculated EPS (Annualised)

36.60

22.78

36.32

29.65

No of Public Share Holdings

58499848

% of Public Share Holdings

55.92

PBIDTM% (Excl OI)

44.06

37.66

42.10

43.99

PBIDTM%

47.29

42.43

45.49

47.39

PBDTM%

47.26

42.32

45.34

47.18

PBTM%

42.97

36.22

41.04

41.56

PATM%

31.82

26.98

30.47

30.96

Notes

Risk Disclosures on Derivatives

Quarterly Results

CONCORD BIOTECH LTD.